{{Rsnum
|rsid=7078
|Gene=MYH9
|Chromosome=22
|position=36281868
|Orientation=minus
|GMAF=0.2011
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MYH9
}}{{PMID Auto
|PMID=19320731
|Title=Further evidence for the involvement of MYH9 in the etiology of non-syndromic cleft lip with or without cleft palate
}}

{{PMID Auto
|PMID=18716610
|Title=Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate.
|OA=1
}}

{{PMID Auto
|PMID=18794854
|Title=MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=18794856
|Title=MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
|OA=1
}}

{{PMID Auto
|PMID=19177153
|Title=Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans.
|OA=1
}}

{{PMID Auto
|PMID=20124285
|Title=Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
|OA=1
}}

{{PMID Auto
|PMID=20144966
|Title=African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}